PALATIN TECHNOLOGIES INC cotiza a 8.19 USD y tiene una capitalización bursátil de $15M. En los últimos 12 meses ha facturado $9M con un margen de flujo de caja libre del -153.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanot…
| Periodo | 2026-09 | 2026-05 | 2026-02 | 2025-05 |
|---|---|---|---|---|
| Real | $-1.11 | $-0.37 | $-2.86 | $-9.92 |
| Estimado | $-1.12 | $-0.82 | $-1.47 | $-8.50 |
| Sorpresa | +0.9% | +54.9% | -94.6% | -16.7% |
| Métrica | PTN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -98.2% | -38.6% | -59.6% |
| Net Margin | -94.9% | -33.6% | -61.3% |
| FCF Margin | -153.8% | -13.9% | -140.0% |
| ROE | -125.3% | -40.4% | -84.9% |
| ROA | -98.3% | -32.0% | -66.3% |
| Current Ratio | 4.61 | 2.84 | +1.77 |
| Debt / Equity | — | 0.28 | — |